Joseph Zakrzewski, executive chairman, Amarin
January 13, 2010Research and Development Amarin, appointment, research and development
Dublin-headquartered biotech Amarin has appointed Joseph Zakrzewski executive chairman. He is currently the chief executive of Xcellerex, a Massachusetts-based biotechnology …
Sanofi Pasteur collaborates on novel biologics
January 12, 2010Research and Development KaloBios, Sanofi, Sanofi Pasteur, cystic fibrosis, infection, vaccines
Sanofi Aventis’ vaccines division has partnered with US biotech KaloBios to develop a number of novel biologic treatments. Sanofi Pasteur …
Manufacturing news in brief
January 12, 2010Manufacturing and Production ACell, Cel-Sci, Dr Reddy's Laboratories, Genzyme, Mannkind, Pfizer, Transgene Biotek, Viva Pharmaceutical
This week’s rundown of manufacturing news includes a delay for Mannkind’s inhaled insulin product Afrezza, more job losses at Pfizer …
Ferring and Stiefel named and shamed for Code breaches
January 12, 2010Medical Communications ABPI, Code of Practice, Ferring, PMCPA, Stiefel
Ferring Pharmaceuticals and Stiefel Laboratories have been named and shamed for breaching the ABPI Code of Practice. Adverts giving details …
Signs of product payoff from GSK’s $1.5bn alliance
January 12, 2010Research and Development ChemoCentryx, Crohn's, GlaxoSmithKline
GlaxoSmithKline is to develop and commercialise a drug which hopes will be a treatment for moderate-to-severe Crohn’s disease. Californian biotech …
Novartis launches Ilaris in the UK
January 12, 2010Sales and Marketing Ilaris, Novartis, cryopyrin-associated periodic syndrome
Novartis has launched its new biologic Ilaris in the UK as a treatment for cryopyrin-associated periodic syndrome. The rare debilitating …
ScopeMedical appoints new medical writer and boosts project team
January 12, 2010Medical Communications ScopeMedical, appointment, medical communications
ScopeMedical has appointed Matthew Booth as a senior medical writer. Matt has nearly 10 years of solid experience within academia …
Rexam shuts down US pharma packaging plant
January 12, 2010Manufacturing and Production Rexam, packaging
Packaging giant Rexam has said it will close its healthcare packaging plant in Nashua, New Hampshire, before the end of …
Transatlantic conversations
January 11, 2010Research and Development EMA, FDA
The Pharmafocus interview: Murray Lumpkin, FDA Deputy Commissioner for International ProgramsCollaborations between the world’s leading medicines regulators have increased markedly …
Michael Moore, chairman, Oxford BioTherapeutics
January 11, 2010Research and Development Oxford Biotherapeutics, Piramed, appointment, research and development
Oxford BioTherapeutics (OBT) has appointed Dr Michael Moore non-executive chairman. He joins the company following five years spent at UK …
FDA approves Roche’s Actemra
January 11, 2010Sales and Marketing Actemra, RoActemra, Roche, US, rheumatoid arthritis
Roche’s Actemra has been approved in the US for the treatment of moderately to severely active rheumatoid arthritis (RA) and …
New regenerative medicine manufacturing centre to be established in UK
January 11, 2010Manufacturing and Production Loughborough, regenerative medicine
A new specialist centre for manufacturing in regenerative medicine is to be set up in the UK with government funding. …
Roche signs genetic chemistry technology deal
January 11, 2010Research and Development Evolva, Roche, genetic chemistry
Roche has signed a deal with Evolva Holding to create anti-infectives and cancer treatments using the latter’s genetic chemistry technology. Roche’s …
Alison Clough promoted to commercial and communications director for the ABPI
January 11, 2010Medical Communications, Research and Development, Sales and Marketing ABPI, appointment, patent box
UK pharma industry association the ABPI has promoted Alison Clough to commercial and communications director. She moves into the new …
Marksans presses on with plan to exit API business
January 11, 2010Manufacturing and Production, Research and Development API, Marksans
India’s Marksans Pharma is seeking approval from its shareholders to divest or lease out its two active pharmaceutical ingredient (API) …
Digital Pharma: Byte-sized roundup
January 8, 2010Medical Communications Diabetes UK, NICE, Shire, ViiV, digital pharma, doctors.net, iphone
Includes online petition against NICE decision, Shire brings ADHD to Twitter, ViiV joins Twitter, Doctors.net.uk launches iPhone app and Diabetes …
NICE says no to Multaq
January 8, 2010Sales and Marketing Multaq, NICE, Sanofi
NICE has rejected Sanofi-Aventis’ new anti-blood clot treatment Multaq (dronedarone) for use on the NHS because of its cost. According …
AstraZeneca’s Bruno Angelici awarded Légion d`honneur
January 8, 2010Sales and Marketing AstraZeneca, France, appointment, sales and marketing
AstraZeneca’s Bruno Angelici has been appointed Chevalier dans l`Ordre National de la Légion d`honneur in the French New Year honours …
More detail needed on Conservative NHS manifesto, says think tank
January 8, 2010Conservatives, NHS, king's fund
The Conservative Party’s draft manifesto on the NHS has been given a cautious welcome by the King’s Fund, which says …
England moves forward on generic substitution
January 8, 2010Sales and Marketing NHS, generics, substitution
The UK Department of Health has started a consultation on proposals that would allow generic medicines to be substituted for …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
